Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
FDA launches new priority review voucher program for select biopharmas
tariffs
Biotech
Taxes, tariffs, interest rates hold key to biotech's future: EY
“This is probably one of the toughest years to predict,” Arda Ural, Ph.D., EY Americas Life Sciences Sector Leader, said on last week.
Kevin Dunleavy
Jun 18, 2025 9:50am
Tariff-driven uncertainty rattles medtech industry
Jun 3, 2025 10:40am
PacBio expands reach in China with clinical distribution deal
May 22, 2025 12:00pm
AdvaMed presses Congress for ‘zero for zero’ medtech tariffs
May 14, 2025 11:40am
Siemens Healthineers to move Varian manufacturing to California
May 14, 2025 10:30am
Roche to spend $550M building Indianapolis HQ into CGM hub
May 13, 2025 12:00pm